Mini Review - Journal of Clinical Cardiology (2021) Volume 2, Issue 4
Left Atrial Dysfunction in Patients with Coronary Slow Flow
Li Liu1,2*, Jing Dong2, Zhiyuan Shui3
1Department of Cardiology, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning Province, China
2Department of Cardiology, The Second Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi
3Department of Cardiology, The Sanmenxia Central Hospital, Sanmenxia, Henan Province, China
- *Corresponding Author:
- Li Liu
Received date: March 14, 2016; Accepted date: September 17, 2021
Citation: Liu L, Dong J, Shui Z. Left Atrial Dysfunction in Patients with Coronary Slow Flow. J Clin Cardiol. 2021; 2(4):69-74.
Copyright: © 2021 Liu L, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The coronary slow flow phenomenon (CSFP) is relatively common in patients scheduled for coronary angiography, characterized
by delayed distal vessel opacification of contrast in the absence of significant epicardial coronary stenosis. Rather than a simple
angiographic curiosity, CSFP has significant clinical implications. Currently, its pathophysiological mechanism remains unclear
although several possible mechanisms have been proposed. There is objective evidence of left ventricular systolic/diastolic dysfunction
in patients with CSFP, however the alteration of left atrium (LA) function is controversial. LA serves an integral role in cardiac
performance and is closely related to left ventricle function. In this review we will address the changes of LA structure and function
in patients with CSFP according to our research and existing literature, therefore provide further insight into its clinical significance
and pathophysiological mechanisms.
Coronary slow flow phenomenon, Left atrium structure and Function, Two-dimensional speckle tracking
echocardiography, Strain, Strain rate
Coronary slow flow phenomenon (CSFP) is not an infrequent angiographic finding in patients scheduled for coronary angiography. The incidence varies from 1% to 5.5% [1-3], although some cardiologists believe it is often underrecognized, its incidence could be as high as 34% . The CSFP was firstly described by Tambe in 1972 in 6 subjects presenting with chest pain syndromes , and now it attracted intensive attention among interventional cardiologists since its original description. The current adapted diagnostic criteria was proposed by John Beltrame in 2012  where CSFP is defined as delayed distal vessel opacification of contrast in the absence of significant epicardial coronary stenosis (coronary artery stenosis ≤40%), with the Thrombolysis in Myocardial Infarction (TIMI) blood flow grade of 2 or corrected TIMI frame count (cTFC) of greater than 27 frames in one or more epicardial vessel. Currently, it’s believed that CSFP is not just a simple angiographic curiosity, it has significant implications in clinical setting. Its pathophysiological mechanism remains unclear, although several possible mechanisms were proposed. In this article, we will summarize the clinical implications, possible mechanisms, and the alteration of cardiac function, especially the changes of left atrial functions in patients with CSFP according to our research and existing literature. Our purpose is to provide further insight into its clinical significance and pathophysiological mechanisms.
The clinical manifestations of patients with CSFP are diverse, but more than 80% of patients can have repeated chest pain episodes that could last for an extended period of time and could also occur at rest [7-9]. The clinical symptoms range from severe, such as acute coronary
syndrome, to mild, such as chest tightness, and sometimes
CSF can even cause fatal ventricular arrhythmias [9,10]
and sudden cardiac death . Studies have shown that
younger patients are more likely to develop CSFP, and the
prevalence is higher in men than women [2,3]. CSFP is
more likely seen in smokers , patients with metabolic
syndrome and high body mass index (BMI) , patients
with anxiety, depression  and sleep apnea ,
patients with high uric acid level  and in patients with
impaired renal function . In a study by Sanati et al.,
hypertension, low high density lipoprotein cholesterol-c
(HDL-c) level and high hemoglobin level were also
considered as independent predictors of this phenomenon
The Pathophysiological Mechanism
Unlike the relatively clear definition, the pathophysiology of CSFP is not fully understood. Several possible mechanisms have been proposed, such as the endothelial dysfunction theory , early atherosclerosis , microvascular disease [20,21], platelet dysfunction , changes in hemorheology [23,24], the ratio of monocyteto- HDL cholesterol , and oxidative stress and local/ systemic inflammatory response [20,26]. Recently, some studies have indicated that lipoprotein-associated phospholipase A2 , plasma choline , or serum salusin beta level  could be a predictive or diagnostic
biomarker for CSFP.
In our recent study , we found that the percentage of monocytes has significant difference between the CSF group and the normal control group, it was an independent risk factor for the occurrence of CSFP by regression analysis, indicating monocytes may play an important role in the development of CSFP. As we know, monocytes involve in the occurrence and development of atherosclerosis, which precipitates the progression of atherosclerotic plaques from a stable state to an unstable state [31,32]. Coronary intravascular ultrasounds have revealed intimal thickening, diffuse vascular wall calcification, and atheromatous plaque formation in the epicardial coronary arteries of CSF patients [19,33], indicating that CSFP may be an early manifestation of coronary atherosclerosis or part of systemic atherosclerosis. In addition, we also noticed a higher prevalence of smoking and a higher BMI in the CSF group than that of the control group, which can be linked with some recent findings. Several studies have shown that smoking can induce endothelial dysfunction through oxidative stress , which is involved in the development of CSFP. Metabolic syndrome (such as obesity, high BMI, diabetes, etc.) has similar effects on vascular endothelium. Obesity and a high BMI can cause endothelial dysfunction through an imbalance in the production of vasodilatory agents, thus inducing CSFP [12,35].
Taken together, CSFP may be caused by gradual progression of endothelial dysfunction, microvascular disease, early atherosclerosis, then resultant microvascular luminal narrowing. The interplay between local and systemic inflammatory response promotes the process.
CSFP and Left Atrial Function
There is objective evidence of left ventricular systolic/ diastolic dysfunction in patients with CSFP [36,37]. However, the effect of CSFP on left atrial function has been minimally investigated. A few studies can be found in the existing literature, but the conclusion is controversial [38,39]. Left atrium plays an important role in ensuring proper performance of left ventricular function and the systemic circulation. It is not just simply a conduit for left ventricular (LV) filling. From hemodynamic perspective left atrium is divided into three phases, LA reservoir, conduit, and pump function, all of which contribute to LV filling [40-42]. Conversely, LV function influences LA function. LA reservoir function is affected by LV contraction and LA compliance. LA pump function is influenced by LV end-diastolic pressure, LV compliance, and LA contractile properties, while LA conduit function is dependent on LV diastolic properties [42,43]. Abnormal left atrial function can affect left ventricular filling and cause a decrease in cardiac output.
Accurate evaluation of the structure and function of the left atrium has important significance in clinic settings. Traditional methods using two-dimensional (2D) echocardiography and Doppler technique for assessment of left atrial function gives limited information depending on hemodynamic loading and geometric measurements  and may not fully reflect the left atrial function. 2D Speckle tracking echocardiography (2D-STE) is a relatively new echocardiographic technique developed for quantitative evaluation of cardiac function. This technology quantifies the movement of the myocardium by tracking the trajectory of the myocardial acoustic spot during the cardiac cycle (Figure 1). It gives an excellent assessment of the atrial deformation profile during an entire cardiac cycle by closely following the LA physiology [43,44]. In contrast to Doppler derived parameters, speckle tracking has the advantages of being angle-independent, less loaddependent than ejection fraction, and less affected by reverberations, side lobes, and drop out artifacts [44,45]. 2D-STE was found to be a feasible, reproducible, and sensitive method to assess LA function . Several studies have shown that strain imaging can detect LA dysfunction before the manifestation of LA structural changes [44-48].
The effect of CSFP on LA functions remains controversial [37,47,48]. Wang et al.  evaluated the LA function in 82 patients with CSFP and compared with normal control participants. They observed decreased LA conduit function and increased LA pump function in patients with CSFP, but no significant differences regarding LA phasic emptying volume and emptying fraction were observed between the two groups. However, in another study with 1:1 patient-control matching design for age, sex, hypertension, diabetes mellitus, and the LV function by Fallah , the authors did not find significant differences
regarding triphasic LA functions assessed through
2D-STE between the CSFP group and control group. In
our study , we found that minimum left atrial volume
index (LAVImin) increased and left atrial ejection fraction
(LA-EF) decreased in the CSFP group compared with
the control group, although no statistically significant
differences were found in the LA size (i.e., antero-posterior
diameter, lateral diameter, and LA length) and maximum
left atrium volume index (LAVIm) between the two groups.
Meanwhile, we found that patients with CSF have lower
LA-mLGS and higher late diastolic strain rate (LA-mSRa),
suggesting an impairment of left atrial reservoir function
and booster function in patients with CSFP. The correlation
test revealed a negative correlation between LA-mGLS and
mTFC, suggesting that the overall LA function will further
decrease with a decrease in coronary blood flow velocity.
CSFP is a multifactorial entity in which endothelial dysfunction and local/systemic inflammatory status may play key roles. Patients with CSFP have variably clinical manifestations and impaired cardiac functions, including LV systolic/diastolic and LA function.
- Paul LC, Jani D, Menete A, Mocumbi AO, Ferreira
B. Coronary slow-flow phenomenon. Cardiovasc J Afr.
- Fineschi M, Gori T. Coronary slow-flow phenomenon or
syndrome Y: a microvascular angina awaiting recognition.
J Am Coll Cardiol. 2010;56:239-40.
- Hawkins BM, Stavrakis S, Rousan TA, Abu-Fadel M,
Schechter E. Coronary Slow Flow Prevalence and Clinical
Correlations. Circulation Journal. 2012;76:936-42.
- Diver DJ, Bier JD, Ferreira PE, Sharaf BL, McCabe
C, Thompson B, et al. Clinical and arteriographic
characterization of patients with unstable angina without
critical coronary arterial narrowing (from the TIMI-IIIA
Trial). Am J Cardiol. 1994;74(6):531-7.
- Tambe AA, Demany MA, Zimmerman HA, Mascarenhas
E. Angina pectoris and slow flow velocity of dye in coronary
arteries-a new angiographic finding. American Heart
- Beltrame JF. Defining the coronary slow flow phenomenon. Circulation Journal. 2012;76(4):818-820.
- Leone MC, Gori T, Fineschi M. The coronary slow
flow phenomenon: A new cardiac “Y” syndrome? Clin
Hemorheol Microcirc. 2008;39:185-90.
- Mangieri E, Macchiarelli G, Ciavolella M, Barillà F,
Avella A, Martinotti A, et al. Slow coronary flow: clinical
and histopathological features in patients with otherwise
normal epicardial coronary arteries. Cathet Cardiovasc
- Wozakowska-Kaplon B, Niedziela J, Krzyzak P, Stec S.
Clinical manifestations of slow coronary flow from acute
coronary syndrome to serious arrhythmias. Cardiol J.
- Sen T, Tufekcioglu O, Golbasi Z, Kisacik H. Clinical
characteristics of patients with coronary slow flow: A
registry study. MN Cardiol. 2011;18:71-4.
- Saya S, Hennebry TA, Lozano P, Lazzara R, Schechter
E. Coronary slow flow phenomenon and risk for sudden
cardiac death due to ventricular arrhythmias: a case report
and review of literature. Clin Cardiol. 2008;31:352-5.
- Yilmaz, H, Demir I, Uyar Z. Clinical and coronary
angiographic characteristics of patients with coronary
slow flow-Acta Cardiologica. 2008;63:579-84.
- Yalvac D, Ozturk S, Sivri N, Kiliç Y, Bulut E, Celik A,
et al. Effects of patients’ anxiety and depression scores on
coronary flow in patients with normal coronary arteries.
Int J Cardiol. 2015;180:55-7.
- Ozeke O, Gungor M, Ertan C, Celik A, Aydin D, Erturk
O, et al. Association of sleep apnea with coronary slowflow
phenomenon. Cardiovasc Med. 2012;13:376-80.
- Naing Z, Qiu CG. Dawn of the most influential
mechanism from the nightmare of slow coronary flow
phenomenon: a randomized controlled study. Int J
- Sobkowicz B, Tomaszuk-Kazberuk A, Kralisz P,
Malyszko J, Kalinowski M, Hryszko T, et al. Coronary
blood flow in patients with end-stage renal disease
assessed by thrombolysis in myocardial infarction frame
count method. Nephrol Dial Transplant. 2010;25:926-30.
- Sanati H, Kiani R, Shakerian F, Firouzi A, Zahedmehr
A, Peighambari M, et al. Coronary slow flow phenomenon:
clinical findings and predictors. Res Cardiovasc Med.
- Beltrame JF, Cutri N, Kopetz V, Tayella R. The role
of nitric oxide in the coronary slow flow phenomenon.
Coronary Artery Disease. 2014;25:187-9.
- Oz O, Bayram NA, Durmaz T, Keles T, Akcay M,
Bozkurt E. The relationship between coronary slow flow
phenomenon and coronary calcium score. Perfusion.
- Wang X, Nie, SP. The coronary slow flow phenomenon:
characteristics, mechanisms and implications. Cardiovasc
Diagn Ther. 2011;1:37-43.
- Beltrame JF, Limaye SB, Wuttke RD, Horowitz
JD. Coronary hemodynamic and metabolic studies
of the coronary slow flow phenomenon. Am Heart J.
- Gökçe M, Kaplan S, Tekelioglu Y, Erdogan T,
Küçükosmanoglu M. Platelet function disorder in patients
with coronary slow flow. Clin Cardiol. 2005;28:145-8.
- Damaske A, Muxel S, Fasola F, Radmacher MC,
Schaefer S, Jabs A, et al. Peripheral hemorheological and
vascular correlates of coronary blood flow. Clin Hemorheol
- Bilgi M, Güllü H, Kozanoglu I, Özdogu H, Sezgin N,
Sezgin AT, et al. Evaluation of blood rheology in patients
with coronary slow flow or non-obstructive coronary artery
disease. Clin Hemorheol Microcirc. 2013; 53:317-26.
- Canpolat U, Çetin EH, Cetin S, Aydin S, Akboga MK,
Yayla C, et al. Association of monocyte-to-HDL cholesterol
ratio with slow coronary flow is linked to systemic
inflammation. Clin Appl Thromb Hemost. 2016;22(5):
- Wang, X, Geng, LL, Nie, SP. Coronary slow flow
phenomenon: a local or systemic disease? Med Hypotheses.
- Ding YD, Pei YQ, Wang R, Yang JX, Zhao YX,
Liu XL, et al. Increased plasma lipoprotein-associated
phospholipase A2 levels are associated with coronary slow
flow. BMC Cardiovasc Disord. 2020;20:248.
- Zhu YT, Zhu LP, Wang ZY, Qiu XT, Wu WZ, Liu WW,
et al. Plasma Choline as a Diagnostic Biomarker in Slow
Coronary Flow. Cardiol Res Pract. 2020;2020:7361434.
- Akyüz, A, Aydin, F, Alpsoy, S Gür, D, Güzel, S.
Relationship of serum salusin beta levels with coronary
slow flow. Anatol J Cardiol. 2019;22(4):177-184.
- Shui Z, Wang Y, Sun M, Gao Y, Liang S, Wang Y, et al.
The effect of coronary slow flow on left atrial structure and
function. Scientific Reports. 2021; 11:7511.
- Chistiakov DA, Grechko AV, Myasoedova VA,
Melnichenko AA, Orekhov AN. The role of monocytosis and neutrophilia in atherosclerosis. J Cell Mol Med.
- Ghattas A, Griffiths HR, Devitt A, Lip GY, Shantsila E.
Monocytes in Coronary Artery Disease and Atherosclerosis
Where Are We Now? J Am Coll Cardiol. 2013;10(22):1541-
- Cin VG, Pekdemir H, Camsar A, Ciçek D, Akkus
MN, Parmaksýz T, et al. Diffuse intimal thickening of
coronary arteries in slow coronary flow. Jpn Heart J.
- Carnevale R, Sciarretta S, Violi F, Nocella C, Loffredo
L, Perri L, et al. Acute Impact of Tobacco vs Electronic
Cigarette Smoking on Oxidative Stress and Vascular
Function. Chest. 2016;150(3):606-12.
- Kwaifa I, Bahari H, Yong YK, Noor S. Endothelial
dysfunction in obesity-induced inflammation: molecular
mechanisms and clinical implications. Biomolecules.
- Nurkalem Z, Gorgulu S, Uslu N, Orhan AL, Alper AT,
Erer B, et al. Longitudinal left ventricular systolic function
is impaired in patients with coronary slow flow. Int J
Cardiovasc Imaging; 2009;25:25-32.
- Wang Y, Ma C, Zhang Y, Guan Z, Liu S, Li Y, et al.
Assessment of left and right ventricular diastolic and
systolic functions using two-dimensional speckle-tracking
echocardiography in patients with coronary slow-flow
phenomenon. PLoS One. 2015;10:e0117979.
- Fallah F, Narimani S, Yarmohammadi S,
Hosseinsabet A, Jalali A. Is left atrial function affected
by coronary slow flow? A two-dimensional speckletracking
echocardiographic study. J Cardiovasc Echogr.
- Li J, Wang Y, Zhao C, Zhu Q, Li G, Yang J, Jia D, Ma C.
Incremental value of three-dimensional echocardiography
for evaluating left atrial function in patients with coronary
slow flow phenomenon: a case control study. Cardiovasc
- Hoit, BD. Left atrial size and function: role in
prognosis. J Am Coll Cardiol. 2014;63:493–505.
- Gan G, Ferkh A, Boyd A, Thomas L. Left atrial
function: evaluation by strain analysis. Cardiovasc Diagn
- Thomas L, Marwick TH, Popescu BA, Donal E, Badano
LP. Left atrial structure and function and left ventricular
diastolic dysfunction: JACC state-of-the-art review. J Am
Coll Cardiol. 2019;73(15):1961-77.
- Barbier P, Solomon SB, Schiller NB, Glantz SA. Left
atrial relaxation and left ventricular systolic function
determine left atrial reservoir function. Circulation.
- Teske AJ, De Boeck BW, Melman PG, Sieswerda
GT, Doevendans PA, Cramer MJ. Echocardiographic
quantification of myocardial function using tissue
deformation imaging, a guide to image acquisition and
analysis using tissue Doppler and speckle tracking.
Cardiovasc Ultrasound. 2007;5:27.
- Cameli, M, Lisi, M, Righini, FM, Mondillo, S. Novel
echocardiographic techniques to assess left atrial size,
anatomy and function. Cardiovasc Ultrasound. 2012;10:4.
- Cameli M, Caputo M, Mondillo S, Ballo P, Palmerini
E, Lisi M, et al. Feasibility and reference values of left atrial
longitudinal strain imaging by two-dimensional speckle
tracking. Cardiovasc Ultrasound. 2009;7:6.
- Yan P, Sun B, Shi H, Zhu W, Zhou Q, Jiang Y, et al.
Left atrial and right atrial deformation in patients with
coronary artery disease: A velocity vector imaging-based
study. PLoS One. 2012;7:e51204.
- Wang Y, Zhang Y, Ma C, Guan Z, Liu S, Zhang W, et al.
Evaluation of left and right atrial function in patients with
coronary slow-flow phenomenon using two-dimensional
speckle tracking echocardiography. Echocardiography,